Ovid Therapeutics Reports Third Quarter 2017 Financial Results and Corporate Progress
NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines for patients with rare neurological diseases, today announced financial results for the third quarter ended …